Home » Newsletters » BioWorld

BioWorld

Feb. 18, 1992

View Archived Issues

U.S. BIOSCIENCE STILL WAITING FOR FDA MEETING

JOINT VENTURE FOR SWEDISH PEPTIDES

COURT DISMISSES CENTOCOR SUIT

NEORX LICENSES PRE-TARGETING TECHNOLOGY

FDA APPROVES COMBINATION HIV TEST

AMOCO UNIT ACQUIRES ECOVA CORP

HYCOR GETS HISTAMINE TECHNOLOGY

PRIVATE PLACEMENT RAISES $11.6M

CYTOTHERAPEUTICS FILES FOR IPO

TRANSGENIC DEVELOPER MAKING IPO .

LIPO FILES TO OFFER 3M SHARES

$29M OFFERING BY ADVANCED TISSUE

CYTORAD SPIN-OFF RAISES $35M

NEW REPORT ON SEPSIS LIFE SAVER